Valneva SE (VALN) EPS (Weighted Average and Diluted) (2021 - 2023)
Valneva SE's (VALN) quarterly EPS (Weighted Average and Diluted) came in at -$127492.3 in Q1 2023, down 22.21% year-on-year from -$163896.6 in Q1 2022, and down 262.45% quarter-over-quarter from $78480.4 in Q3 2022.
Valneva SE (VALN) EPS (Weighted Average and Diluted) (2021 - 2023) Analysis & Trends
Valneva SE has disclosed EPS (Weighted Average and Diluted) across 3 years of filings, most recently posting -$127492.3 for Q1 2023.
- EPS (Weighted Average and Diluted) for Q1 2023 came in at -$127492.3, down 22.21% year-over-year; the trailing twelve-month figure through Mar 2023 was -$127492.3 (down 22.21% YoY), and the FY2025 annual result was -$0.79, down 825.92% from the prior year.
- EPS (Weighted Average and Diluted) came in at -$127492.3 for Q1 2023 at Valneva SE, down from $78480.4 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $78480.4 in Q3 2022 to a low of -$127492.3 in Q1 2023.
- The 3-year median for EPS (Weighted Average and Diluted) is -$83550.3 (2021), against an average of -$54028.1.
- Across the five-year window, EPS (Weighted Average and Diluted) jumped 225.01% in 2022 and fell 22.21% in 2023, its largest moves.
- Valneva SE's EPS (Weighted Average and Diluted) stood at -$62779.7 in 2021, then surged by 225.01% to $78480.4 in 2022, then tumbled by 262.45% to -$127492.3 in 2023.
- The last three EPS (Weighted Average and Diluted) figures came in at -$127492.3 (Q1 2023), $78480.4 (Q3 2022), and -$104320.8 (Q1 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3,086.42 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.02 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.61 |
| 10 | Valneva SE | 163.67 Mn | 40.43 Mn | 5.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | -127,492.31 |
| Sep 30, 2022 | 78,480.43 |
| Mar 31, 2022 | -104,320.83 |
| Sep 30, 2021 | -62,779.68 |